TRIM47 antibody (AA 206-624)

Catalog No. ABIN7872103

The Rabbit Polyclonal anti-TRIM47 antibody (ABIN7872103) specifically detects TRIM47 in WB, ELISA, IHC, IF and ICC. The antibody is reactive with Human, Mouse and Rat samples.

Quick Overview for TRIM47 antibody (AA 206-624) (ABIN7872103)

Target: TRIM47 (Tripartite Motif Containing 47 (TRIM47))

Reactivity: Human, Mouse, Rat

Host: Rabbit

Clonality: Polyclonal

Conjugate: This TRIM47 antibody is un-conjugated

Application: Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF), Immunocytochemistry (ICC)

Product Details anti-TRIM47 Antibody

Binding Specificity: AA 206-624

Purpose: TRIM47 Antibody / Tripartite motif-containing protein 47

Purification: Immunogen affinity purified

Immunogen: E.coli-derived human TRIM47 recombinant protein (Position: A206-I624) was used as the immunogen for the TRIM47 antibody.

Isotype: IgG

Application Details

Application Notes: Optimal dilution of the TRIM47 antibody should be determined by the researcher.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Adding 0.2 mL of distilled water will yield a concentration of 500 μg/mL

Buffer: Each vial contains 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na2HPO4.

Storage: 4 °C,-20 °C

Storage Comment: After reconstitution, the TRIM47 antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.

Target Details for TRIM47

Target: TRIM47 (Tripartite Motif Containing 47 (TRIM47))

Alternative Name: TRIM47

Background: TRIM47 antibody detects Tripartite motif-containing protein 47, an E3 ubiquitin ligase that regulates protein degradation, signal transduction, and immune responses. The UniProt recommended name is Tripartite motif-containing protein 47 (TRIM47). This protein is a member of the TRIM family characterized by the RING finger, B-box, and coiled-coil domains that define its ubiquitin ligase function and protein interaction capacity.

Functionally, TRIM47 antibody identifies a 638-amino-acid cytoplasmic and nuclear protein that facilitates ubiquitination of target substrates, marking them for proteasomal degradation or functional modification. TRIM47 modulates diverse cellular pathways, including interferon signaling, MAPK activation, and cell cycle regulation. Its ligase activity controls turnover of key signaling mediators, contributing to immune homeostasis and stress response.

The TRIM47 gene is located on chromosome 17q24.3 and is expressed in multiple tissues, including brain, kidney, and endothelial cells. TRIM47 interacts with adaptor proteins and kinases to regulate NF-kappaB activation, antiviral defense, and inflammatory signaling. It has also been implicated in the regulation of apoptosis and autophagy, linking ubiquitin signaling to cellular stress adaptation. TRIM47 may influence the degradation of misfolded or damaged proteins during oxidative or inflammatory stress.

In cancer biology, TRIM47 acts as an oncogenic factor in glioma, lung adenocarcinoma, and prostate cancer, where it promotes proliferation and metastasis by modulating MAPK and STAT3 pathways. Overexpression correlates with poor prognosis and enhanced resistance to apoptosis. Conversely, loss of TRIM47 activity may impair innate immune signaling, reducing antiviral defenses and inflammatory gene activation.

TRIM47 antibody is widely used in studies of ubiquitin signaling, innate immunity, and cancer biology. It is suitable for western blotting, immunoprecipitation, and immunofluorescence to examine TRIM47 expression and interactions. In immunology, this antibody supports investigations of antiviral pathways and cytokine regulation. In oncology, TRIM47 serves as a potential biomarker of tumor aggressiveness and therapeutic resistance.

Structurally, TRIM47 contains a RING-type zinc-binding motif conferring E3 ligase activity, B-box domains for stability, and a coiled-coil region for multimerization. Its C-terminal PRY/SPRY domain mediates substrate recognition and specificity. NSJ Bioreagents provides TRIM47 antibody reagents validated for use in ubiquitin signaling, immune regulation, and cancer research.

UniProt: Q96LD4